Polyamine transport inhibitors as antivirals
US11752113B2 · kind B2 · utility
0Cited by
5References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 8, 2021 |
| Grant date | Sep 12, 2023 |
| Priority date | — |
| Expiry date | Sep 8, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are polyamine transport inhibitors (PTI) and methods of use as antivirals. Disclosed PTI compounds are useful as treatments for viral infections or can be used as prophylactic agents that protect high risk individuals from becoming infected by the virus. The disclosed PTI compounds can be used alone or in combination with other agents (or other antivirals) to improve patient outcomes such as DFMO (or Remdesivir).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.